23rd May 2023 Plain Language Summary: the results from two phase 3 studies on the efficacy and safety of daridorexant in patients with chronic insomnia disorder:
22nd May 2023 Plain Language Summary: Is ravulizumab a suitable long-term treatment option for patients with paroxysmal nocturnal hemoglobinuria?
16th May 2023 Plain Language Summary: the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies